Discovering LRATD1: A Potential Drug Target for Various Diseases

Target Name: LRATD1

NCBI ID: G151354

LRATD1

Discovering LRATD1: A Potential Drug Target for Various Diseases

LRATD1 (Launchpad-Record-Activator Transmembrane protein 1) is a protein that is located in the endoplasmic reticulum (ER) and is involved in the regulation of protein function, specifically in the context of protein-protein interactions. LRATD1 has been shown to play a crucial role in the regulation of cellular processes such as cell adhesion, migration, and survival.

Recent studies have identified LRATD1 as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. LRATD1 has also been shown to be involved in several diseases, including neurofibrillary tangles and neurodegeneration, which are thought to be caused by the build-up of misfolded proteins, including amyloid peptides and tau tangles.

The discovery and characterization of LRATD1 began in the late 1990s, when researchers identified a protein that was expressed in the ER and was involved in the regulation of protein function. Subsequent studies have shown that this protein is LRATD1, and that it plays a crucial role in the regulation of protein-protein interactions and the retrieval of exogenous proteins from the ER.

LRATD1 is a transmembrane protein that is composed of a catalytic center, a transmembrane region, and an intracellular region. The catalytic center is the site of LRATD1's protein-protein interaction activity, and is thought to play a role in the regulation of protein-protein interactions by affecting the conformation and activity of the interacting proteins.

The transmembrane region of LRATD1 is responsible for the regulation of the activity of the catalytic center and for the maintenance of the protein's localization to the ER. This region has been shown to be involved in the regulation of several cellular processes, including the regulation of protein folding and the detoxification of foreign particles.

The intracellular region of LRATD1 is responsible for the regulation of the activity of the catalytic center and for the maintenance of the protein's localization to the ER. This region has been shown to be involved in the regulation of several cellular processes, including the regulation of protein folding and the detoxification of foreign particles.

LRATD1 has been shown to play a crucial role in the regulation of protein-protein interactions and in the retrieval of exogenous proteins from the ER. Several studies have shown that LRATD1 promotes the loading of exogenous proteins into the ER and that it plays a role in the regulation of the retention of exogenous proteins in the ER.

In addition to its role in protein-protein interactions and exogenous protein retrieval, LRATD1 has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and survival. LRATD1 has also been shown to be involved in the regulation of several cellular processes, including the regulation of cell adhesion, migration, and the response to mechanical stress.

The potential clinical applications of LRATD1 as a drug target are vast. LRATD1 has been shown to play a role in the regulation of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. LRATD1 has also been shown to be involved in the regulation of several cellular processes that are thought to be involved in the development and progression of these diseases.

For example, LRATD1 has also been shown to play a role in the regulation of neurofibrillary tangles and neurodegeneration, which are thought to be caused by the build-up of misfolded proteins, including amyloid peptides and tau tangles. role in the regulation of protein-protein interactions and in the retrieval of exogenous proteins from the ER, which are thought to be involved in the regulation of

Protein Name: LRAT Domain Containing 1

Functions: May play a role in cell morphology and motility

The "LRATD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRATD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets